Загрузка...
Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer
PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...
Сохранить в:
| Опубликовано в: : | J Urol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/ https://ncbi.nlm.nih.gov/pubmed/25524243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|